Use of pharmacokinetic-pharmacodynamic target attainment analyses to support phase 2 and 3 dosing strategies for doripenem.

Source:http://linkedlifedata.com/resource/pubmed/id/16127078

Download in:

View as

General Info

PMID
16127078